Skip to main content
Premium Trial:

Request an Annual Quote

Researchers to Study Genetic Variation in Drosophila Using Affy Resequencing Arrays

NEW YORK, April 1 (GenomeWeb News) - A consortium of researchers led by the University of California, Davis, has received a $4.9 million grant from the National Human Genome Research Institute to study genetic variation in 50 Drosophila melanogaster strains, Affymetrix said yesterday.


The consortium includes scientists from UC Davis, Johns Hopkins University, Children's Hospital Oakland Research Institute, Emory University, and Affymetrix.


The researchers plan to resequence two large regions of the Drosophila genome using resequencing arrays from Affymetrix, and to develop methods to analyze the data. All sequencing data will be made publicly available as it is generated, and all software developed for the project will be open-source.


Affymetrix is providing its CustomSeq arrays, which it plans to commercialize, for the project under an early technology access program.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.